News Listing

Filter by
Date
Jun 26, 2008 06:00 AM

Are the benefits of growth hormone in the athlete's mind?

A new study undertaken by scientists in Garvan's Pituitary Research Unit demonstrates the 'placebo effect' in sport. If athletes believe they are using a performance-enhancing drug, they may think their performance impro...

Jun 19, 2008 01:00 AM

Garvan cancer researcher wins Premier's Award

Garvan researcher Rebecca Hinshelwood received the highly coveted $10,000 Premier’s Award for Outstanding Cancer Research Scholar at a gala ceremony last month. The award, from the Cancer Institute of NSW, is a form of e...

MEDIA RELEASE: May 14, 2008 04:00 PM

Study shows that prostate cancer increases the risk of bone ...

As unlikely as it sounds, scientists at Garvan have shown that there is a link between prostate cancer and a higher risk of bone fracture. Their study suggests that men with prostate cancer face a 50% higher risk of frac...

MEDIA RELEASE: May 01, 2008 01:00 AM

Genotyping takes us closer to an osteoporosis fingerprint

Garvan collaborated with the Icelandic genetics company, deCode, in an extensive multi-nation genome-wide search to find the genes linked to osteoporosis and fracture. Five regions of interest have been identified that a...

MEDIA RELEASE: Mar 25, 2008 11:00 PM

Targeting aggressive breast cancers by putting them to sleep...

Dr Alex Swarbrick, head of Garvan's Tumour Progression Research Group, has published findings that Id1, a gene produced by the most aggressive forms of breast cancer, can control breast cancer growth. He has shown that b...

MEDIA RELEASE: Mar 23, 2008 09:00 AM

A tonne of bitter melon produces sweet results for diabetes

Teams from the Garvan Institute of Medical Research and the Shanghai Institute of Materia Medica pulped roughly a tonne of fresh bitter melon and extracted four very promising bioactive components that explain why it is ...

MEDIA RELEASE: Mar 11, 2008 01:00 AM

Low levels of PYY hormone a very early indicator of Type 2 d...

Garvan scientists have published findings showing that low levels of the hormone PYY could be used as a predictor for the development of Type 2 diabetes. Clinical studies have shown that people with a family history of T...

MEDIA RELEASE: Mar 07, 2008 02:05 PM

Silencing of molecular 'conversation' may help curb severe a...

Scientists in Sydney have identified a process, a synergistic encounter between two molecules, that may account for the extreme allergic reactions some people experience. By silencing at least one of these molecules, it ...

MEDIA RELEASE: Mar 07, 2008 02:05 PM

Web-based tool to predict risk of bone fracture

Scientists from Garvan have developed a fracture risk calculator using data, accumulated over 17 years, from the internationally recognised Dubbo Osteoporosis Epidemiology Study. A paper describing the tool and its metho...

MEDIA RELEASE: Feb 29, 2008 07:00 PM

B cell mutations that may cause cancers and autoimmune disea...

Scientists at the Garvan Institute of Medical Research have taken a significant step towards demystifying a critical process within our immune system.

Jan 22, 2008 03:00 AM

Garvan scientist wins Academy of Science Award

Dr Vanessa Hayes, Head of Garvan's Cancer Genetics Group, has been honoured by the Australian Academy of Science with the inaugural Ruth Stephens Gani Medal for her work in human genetics. The Medal is one of only seven ...

MEDIA RELEASE: Jan 16, 2008 07:00 AM

Low testosterone in men doubles their risk of bone fracture

Garvan researchers have shown that low levels of testosterone in men double their risk of bone fracture, all other risk factors being equal. This is a significant finding given that 30% of the 110,000 osteoporotic fractu...

MEDIA RELEASE: Jan 09, 2008 07:00 AM

Natural gut hormones may provide a treatment for obesity

Garvan researchers have shown that a hormone released naturally from the gut could be used to treat obesity and Type 2 diabetes. After a meal, the hormone peptide YY (PYY) is released from the gut and acts on the brain, ...

Dec 18, 2007 02:00 AM

Garvan student wins prestigious immunology award

At its annual conference in early December, the Australasian Society of Immunology awarded Garvan PhD student, Sandra Gardam, its prestigious New Investigator Award. Sandra's research looks at B cells, the cells that pro...

Dec 07, 2007 12:00 AM

New Fellowship Strengthens Garvan Potential to find a cure f...

We are very pleased to announce the establishment of the GlaxoSmithKline Don Chisholm Fellowship for Diabetes Research – a position dedicated to vital research into the causes, processes and treatments for Type 2 diabete...

MEDIA RELEASE: Nov 15, 2007 03:00 AM

Creating indestructible insulin-producing cells

Dr Shane Grey, head of Garvan's Gene Therapy and Autoimmunity Group, has received $350,000 from the Juvenile Diabetes Research Foundation, as part of their Australian Islet Transplantation Program. The grant will help hi...

Nov 05, 2007 08:00 PM

The molecule that can switch appetite off and on

Researchers from the St Vincent’s Campus have identified the molecule responsible for the extreme weight loss common in late stage cancer. The findings published online in Nature Medicine suggest it may soon be possible ...

MEDIA RELEASE: Oct 19, 2007 08:00 AM

How Garvan Tall Poppy searches for prostate cancer gene

Dr Vanessa Hayes, head of the Cancer Genetics Group at the Garvan Institute of Medical Research, has received a prestigious New South Wales Young Tall Poppy Science Award in recognition of her research in prostate cancer...

MEDIA RELEASE: Oct 05, 2007 02:00 AM

Cancer genetics to combine forces with nanotechnology to fig...

Associate Professor Susan Clark, head of Garvan’s Epigenetics Research Group, will play a leading role in a $5 million national research program called "Nanoscaled epigenetic biosensors: How combining two novel technolog...

MEDIA RELEASE: Oct 04, 2007 04:00 PM

Solving a critical part of the insulin puzzle

We are now one step closer to improved treatment of Type 2 diabetes following significant findings made by scientists at the Garvan Institute of Medical Research. The team from Garvan's Diabetes Signalling Unit, led by A...

Sep 26, 2007 11:00 AM

Grant paves way to finding potential cure for Type 1 diabete...

Dr Shane Grey, head of Garvan’s Gene Therapy and Autoimmunity Group, has been awarded a $3 M Program Grant, a joint initiative between the National Health and Medical Research Council (NHMRC) and the Juvenile Diabetes R...